Robert F. Kennedy Jr.’s campaign to “Make America Healthy Again” is facing serious challenges. The latest turbulence comes from the FDA, where a key official, George Tidmarsh, resigned amid controversy. Tidmarsh, who led the FDA’s Center for Drug Evaluation and Research, is at the center of a lawsuit from Aurinia Pharmaceuticals. The company claims he harmed their reputation by criticizing its drug voclosporin on LinkedIn, stating it hasn’t shown direct clinical benefits. After his comments, Aurinia’s stock fell 20%.
The lawsuit paints Tidmarsh as someone who sought revenge against Aurinia’s chairman, Kevin Tang, claiming he threatened to get back at him over the years. Tidmarsh has denied these allegations.
Critics have also noted that under Tidmarsh’s leadership, the FDA shifted away from thorough expert reviews of new drugs. Tidmarsh himself said that these reviews were “a tremendous amount of work” and the agency wanted to focus on bigger issues.
With Tidmarsh’s exit, the FDA is left in disarray. Text messages from FDA staff show a sense of frustration and uncertainty. Many experienced officials have already left, prompting fears of further departures.
Kennedy’s brief tenure as health czar has been marked by upheaval. The Department of Health and Human Services (HHS) has seen thousands of employees let go, and several leaders from the CDC have resigned in response to his policies. In a rare move, six former U.S. Surgeons General wrote an op-ed calling Kennedy a significant threat to public health.
Statistics reveal a worrisome trend: surveys show a growing distrust in health agencies, with many Americans questioning their effectiveness. A recent poll indicated that only 36% of people feel confident in the FDA’s ability to ensure drug safety.
This ongoing chaos raises concerns about the future of public health in the U.S. It highlights the importance of stability in health leadership and the need for rigorous oversight in drug approval processes.
For more on the recent controversies surrounding the FDA, you can check detailed coverage from ABC News.
Source link
FDA,HHS,RFK Jr
